Virax Biolabs GroupVRAX 
$1.72-10.42%24h
-10.42%24h
Global rank32535
Market cap$3.12M
Change 7d-16.10%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Virax Biolabs Group (VRAX)
As of January 2025, Virax Biolabs Group has a market cap of $3.12M. This makes Virax Biolabs Group the world's 32535th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Virax Biolabs Group from 2022 to 2024
-
Value:-
Market cap history of Virax Biolabs Group from 2022 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.48M | -44.11% |
| 2023 | $2.64M | -80.00% |
| 2022 | $13.22M | - |
VRAX Market Cap Today is $3.12M -10.42% - 2 Jan 2025
View largest stocks by market cap 
